NCT05936541View on ClinicalTrials.gov

Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 5, 2020

Primary Completion Date

May 2, 2021

Study Completion Date

May 25, 2021

Conditions
Disbiosis
Interventions
DIETARY_SUPPLEMENT

Probiotic Bifidobacterium Bifidum PRL2010

Probiotic supplement

OTHER

Control group

No probiotic supplementation

Trial Locations (1)

LT 04100

Neonatology and Neonatal Intensive Care Unit of Santa Maria Goretti Hospital, Latina

All Listed Sponsors
collaborator

Ospedale Santa Maria Goretti

OTHER

lead

Liaquat University of Medical & Health Sciences

OTHER

NCT05936541 - Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants | Biotech Hunter | Biotech Hunter